Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.900
-0.180 (-8.65%)
At close: Jul 8, 2026, 4:00 PM EDT
1.930
+0.030 (1.58%)
After-hours: Jul 8, 2026, 7:00 PM EDT
BDTX Market Cap
BDTX has a market cap or net worth of $108.87 million as of July 8, 2026. Its market cap has decreased by -15.65% in one year.
Market Cap
108.87M
Enterprise Value
8.50M
1-Year Change
-15.65%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $108.87M, a decrease of -91.97%. That is a compound annual growth rate of -32.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 108.87M | -21.36% |
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 119.72M |
| Cue Biopharma | 114.41M |
| Kalaris Therapeutics | 113.25M |
| NeOnc Technologies Holdings | 113.07M |
| Vivani Medical | 112.11M |
| Anixa Biosciences | 108.70M |
| Oncolytics Biotech | 106.43M |
| Cibus | 106.10M |